Coverage of our peer-reviewed research in the healthcare and mainstream press.
The National Pharmaceutical Council’s daily newsletter e-mail on January 5 highlighted a news article by The American Journal of Managed Care® (AJMC®)'s Surabhi Dangi-Garimella, PhD. The article, “HTA Study Raises Questions on Real-World Benefits of Newly Approved Cancer Drugs,” examined the findings of a retrospective study in JAMA Oncology that “analyzed health technology assessment reports for 62 new anticancer drugs approved in Europe and the United States” in a 10-year timeframe. It indicated that real-world benefits like overall survival vary widely by drug and by disease type.
A recent AJMC® infographic, “Making Sense of MACRA,” which summarized the timelines and options associated with the Quality Payment Program established under the Medicare Access and CHIP Reauthorization Act (MACRA), was cited in an EHR Intelligence article, “Avoiding Financial Implications of Quality Payment Program.” In the article, author Sara Heath used the infographic’s timeline to explain how physicians can avoid negative payment adjustments under the new rule.
A Watchdog article imploring readers to “Meet the Nonprofit That Helps State Governments Ration Your Health Care” profiled the Institute for Clinical and Economic Review (ICER). Author Johnny Kampis quoted an interview between Dangi-Garimella, of AJMC®'s Evidence-Based Oncology™, and ICER president and founder Steven Pearson, MD, MSc, FRCP, in which he discussed the group’s payer-focused framework.
In an article by Vera Gruessner, Health Payer Intelligence summarized the findings of a study from the recent Evidence-Based Diabetes Management™ special issue with the American Association of Diabetes Educators. The research, “Diabetes Educators in Accountable Care Organizations: Meeting Quality Measures Through Diabetes Self-Management Education and Care Coordination,” explained how diabetes educators can be a valuable resource in managing this chronic disease.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More